Press release
Global Uveitis Treatment Market is Expected to Represent US$ 847.8 Mn by 2024-End
In its recently published report titled “Uveitis Treatment Market: Industry Analysis and Forecast, 2016–2024,” the company provides in-depth analysis of the market growth prospects for the eight-year assessment period, backing it up with historic and current market data.
View and Download TOC of Uveitis Market Research Report@ https://www.persistencemarketresearch.com/market-research/uveitis-market/toc
Persistence Market Research identified a few important drivers and trends that will continue to present attractive growth opportunities during 2016-2024.
While surge in autoimmune disorders is identified to primarily generate the demand for uveitis, the market has been witnessing strong emergence of immunosuppressive therapies to treat uveitis since the past few years, which is expected to create a new set of opportunities for leading players in near future.
Request and Download Sample Report@ https://www.persistencemarketresearch.com/samples/3596
Corticosteroids will remain the largest segment, followed by antibiotics and monoclonal antibodies. While corticosteroids segment is foreseen to account for a dominant market share of over 21% in 2024, antibiotics segment is expected to witness the fastest growth at a CAGR of 8% – reaching beyond US$ 146 Mn over 2016-2024. Monoclonal antibodies segment will also exhibit healthy growth at a CAGR of 7%, reaching revenues worth US$ 142.7 Mn by the end of 2024.
North America, the largest and fastest growing regional market for uveitis treatment globally, will retain its dominant position over the assessed period. With over 34% market value share in 2024, this regional will possibly account for around US$ 290 Mn. Europe will remain the second key market with nearly 27% share by the end of forecast period, followed by Asia Pacific.
The report profiles key market players and highlights their recent activities supporting market growth.
Allergan, Inc., Novartis AG (ALCON), Valeant Pharmaceuticals International, Inc., AbbVie Inc., Eyegate Pharmaceuticals, Inc., Alimera Sciences Inc., and pSivida Corp. are some of the key players in the global uveitis treatment market.
Among these, Allergan, Valeant, and Novartis constitute the most prominent companies. Eyegate is also actively involved through strategic acquisitions.
Allergan, in 2016, acquired a gene therapy company RetroSense Therapeutics to enhance the company’s eye care product pipeline. Later, the same year, Allergan launched an influential uveitis drug Taytulla.
Novartis recently acquired Encore Vision, Inc. in 2016, to strengthen its ophthalmology pipeline.
Recently in 2015, Eyegate signed a licensing agreement with Valeant for an effective combination product against uveitis. More recently in 2016, the company announced the acquisition of Jade Therapeutics, Inc. and stepped into treatment for poorly-served ophthalmic indications.
Buy Full Uveitis Market Report@ https://www.persistencemarketresearch.com/checkout/3596
About Us
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.
Contact
Persistence Market Research Pvt. Ltd
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
media@persistencemarketresearch.com
Web:www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Uveitis Treatment Market is Expected to Represent US$ 847.8 Mn by 2024-End here
News-ID: 716783 • Views: …
More Releases from Persistence Market Research
Cloud Based Payroll Software Market Expected to Hit USD 23.3 Billion by 2031, Gr …
Overview of the Market
The global cloud based payroll software market has emerged as a pivotal segment within the broader human resources technology landscape. Valued at US$11.7 billion in 2024, the market is projected to reach US$23.3 billion by 2031, registering a CAGR of 10.3% during the forecast period. This rapid expansion is driven by the increasing adoption of automation, artificial intelligence (AI), and cloud-based platforms that streamline payroll processes, reduce…
U.S. Ready-to-Drink Cocktails Market to Hit $2,374.9 Mn by 2032, Driven by Premi …
The U.S. ready-to-drink (RTD) cocktails market is entering an accelerated growth phase, driven by evolving consumer preferences, convenience-focused lifestyles, and innovation within the alcoholic beverage industry. According to the latest analysis, the market is expected to be valued at US$ 943.3 million in 2025 and is projected to reach US$ 2,374.9 million by 2032, registering a robust compound annual growth rate (CAGR) of 14.1% between 2025 and 2032.
Growth is primarily…
Food Fiber Market to Reach $17.02 Bn by 2032, Driven by Health Trends and Digest …
The global food fiber market is set to enter a robust growth phase over the next decade. According to Persistence Market Research, the market is projected to be valued at US$10.01 Bn in 2025 and is expected to reach US$17.02 Bn by 2032. This expansion represents a strong CAGR of 7.9% during the forecast period from 2025 to 2032. Rising awareness about the health benefits of dietary fibers, increasing incidences…
Polymer Tantalum Capacitors Market Projected to Reach USD 1,203.0 Million by 203 …
Overview of the Market
The global polymer tantalum capacitors market is witnessing robust growth, with its valuation expected to rise from US$739.8 million in 2024 to US$1,203.0 million by 2031, reflecting a CAGR of 7.2% during the forecast period. The increasing adoption of high-performance electronic devices, miniaturization of components, and growing demand from electric vehicles (EVs) are among the primary factors driving market expansion. These capacitors are recognized for their high…
More Releases for Uveitis
Uveitis Market : An Overview Report
Introduction:
Uveitis is an inflammatory condition affecting the uvea, the middle layer of the eye. It can lead to vision impairment or even blindness if left untreated. Uveitis is categorized into different types, including anterior, intermediate, posterior, and panuveitis, depending on the part of the eye affected. The condition can be caused by infections, autoimmune diseases, or trauma. With increasing cases of autoimmune disorders and infectious diseases, the prevalence of uveitis…
Uveitis Treatment Market Size, Share | Trend 2030
Exclusive Report by Ameco Research: Uveitis Treatment Market Size Projected to Reach USD 2 Billion by 2030, Growing at 6% CAGR
Ameco Research is proud to announce the launch of its latest market research report, Uveitis Treatment Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research…
Uveitis - Drug Pipeline Landscape, 2022
New York, Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of…
Uveitis - Drug Pipeline Landscape, 2022
Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of uveitis based…
Japan Industry Statistics of Uveitis Treatment
Global Uveitis Treatment Market: Overview
Uveitis, an autoimmune eye disease, is considered rare for just around 38 in 100,000 people are afflicted by it. Because of this, it is often overlooked. Patients afflicted by uveitis are often referred to an expert after much delay on account of less awareness about the eye malady. This delays timely diagnosis and results in irreversible damage to various ocular structures.
Read Report Overview: https://www.transparencymarketresearch.com/uveitis-treatment-market.html
As per Cochrane,…
Uveitis Treatment Market Analysis of Top industry Scenario
Global Uveitis Treatment Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables).
According to a new report published by Allied Market Research, titled, "Uveitis Treatment Market by Drug Class (Anti-inflammatory, Antimicrobial Drugs, Immunotherapy &…
